MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
47
Registration Number
NCT00049660
Locations
🇫🇷

Centre Henri Becquerel, Rouen, France

🇫🇷

Institut Bergonie, Bordeaux, France

🇧🇪

Algemeen Ziekenhuis Sint-Augustinus, Wilrijk, Belgium

and more 9 locations

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
35
Registration Number
NCT00028873
Locations
🇫🇷

CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France

🇧🇪

Institut Jules Bordet, Brussels, Belgium

Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura

Phase 3
Completed
Conditions
Malignant Mesothelioma
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
256
Registration Number
NCT00004920
Locations
🇬🇧

Western General Hospital, Edinburgh, Scotland, United Kingdom

🇧🇪

U.Z. Gasthuisberg, Leuven, Belgium

🇵🇱

Regional Lung Diseases Hospital, Poznan, Poland

and more 23 locations

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Phase 3
Terminated
Conditions
Lung Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
158
Registration Number
NCT00003803
Locations
🇳🇱

Radiotherapeutisch Instituut-(Riso), Deventer, Netherlands

🇳🇱

Sophia Ziekehuis, Zwolle, Netherlands

🇳🇱

Antoni van Leeuwenhoekhuis, Amsterdam, Netherlands

and more 14 locations

Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
116
Registration Number
NCT00005980
Locations
🇦🇹

Ludwig Boltzmann - Institute for Applied Cancer Research, Vienna, Austria

🇬🇷

University of Ioannina, Ioannina, Greece

🇨🇭

Clinique De Genolier, Genolier, Switzerland

and more 11 locations

Boron Neutron Capture Therapy Following Surgery in Treating Patients With Glioblastoma Multiforme Removed During Surgery

Phase 1
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
36
Registration Number
NCT00004015
Locations
🇦🇹

Karl-Franzens-University Graz, Graz, Austria

🇩🇪

Universitaetsklinikum Essen, Essen, Germany

🇳🇱

Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands

and more 5 locations

Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy

Phase 3
Terminated
Conditions
Breast Cancer
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
26
Registration Number
NCT00028704
Locations
🇨🇱

Instituto de Radiomedicina, Santiago, Chile

🇵🇹

Hospitais da Universidade de Coimbra (HUC), Coimbra, Portugal

🇵🇱

Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland

and more 10 locations

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Phase 2
Completed
Conditions
Sarcoma
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
39
Registration Number
NCT00041236
Locations
🇩🇰

Aarhus University Hospital - Aarhus Sygehus - Norrebrogade, Aarhus, Denmark

🇩🇪

Universitatsklinikum Carl Gustav Carl Carus, Dresden, Germany

🇩🇪

Eberhard Karls Universitaet, Tuebingen, Germany

and more 7 locations

Mistletoe Lectin in Treating Patients With Refractory Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2003-01-27
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
26
Registration Number
NCT00006477
Locations
🇳🇴

Norwegian Radium Hospital, Oslo, Norway

🇩🇪

Klinikum der J.W. Goethe Universitaet, Frankfurt, Germany

Involved-Field Radiation Therapy in Treating Patients With Previously Untreated Stage I or Stage II Low-Grade Non-Hodgkin's Lymphoma

Phase 3
Terminated
Conditions
Lymphoma
First Posted Date
2003-01-27
Last Posted Date
2012-07-16
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
204
Registration Number
NCT00014326
Locations
🇧🇪

U.Z. Gasthuisberg, Leuven, Belgium

🇭🇷

University Hospital Rebro, Zagreb, Croatia

🇳🇱

Daniel Den Hoed Cancer Center at Erasmus Medical Center, Rotterdam, Netherlands

and more 12 locations
© Copyright 2025. All Rights Reserved by MedPath